Our Ambition:
miDiagnostics wants to bring miniaturized, rapid, easy-to-use, lab-quality tests with
miDiagnostics wants to bring miniaturized, rapid, easy-to-use, lab-quality tests with
Location: Belgium, Flemish Brabant, Heverlee
Employees: 51-200
Total raised: $69.8M
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | Pamica | pamica.be |
| - | Smile Inve... | smile-inve... |
| - | Johns Hopk... | ventures.j... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 09.12.2024 | Series D | $31.71M | - |
| 09.12.2021 | - | $22.63M | - |
| 26.03.2020 | - | $15.47M | - |
Mentions in press and media 12
| Date | Title | Description |
| 22.05.2025 | Belgium’s bold tech revolution at the heart of Europe | Belgium's tech ecosystem is showing strong signs of growth, maturation, and increasing global relevance. According to European Tech 2024: The Big Picture, Belgian tech companies raised over €4.2 billion in 2024. Major deals included funding... |
| 09.12.2024 | miDiagnostics: €30 Million (Series D) Raised To Accelerate Development Of Sterility Test | miDiagnostics announced the completion of a €30 million Series D funding round led by Thermo Fisher Scientific. This funding will accelerate the development of a groundbreaking sterility test for batch release and related quality control te... |
| 04.12.2024 | miDiagnostics Raises €30M in Series D Funding | miDiagnostics, a Leuven, Belgium-based qPCR technology company developing tests directly to patients and clinicians, raised €30M in Series D funding. The round was led by Thermo Fisher Scientific Inc. (NYSE: TMO) with participation from Aly... |
| 04.12.2024 | miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific | LEUVEN, BELGIUM, December 4, 2024 /EINPresswire.com/ -- miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharm... |
| 02.05.2022 | miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test | LEUVEN, BELGIUM, May 2, 2022 /EINPresswire.com/ -- miDiagnostics, a fast-growing POC diagnostics company announces the launch of its CE-IVD certified ultra-fast COVID-19 PCR test. The test is now available for use across Europe and other co... |
| 23.12.2021 | EyeD Pharma raises ⬠32M funding round | Liege, 22 December 2021 - The Liège-based pharmaceutical company, EyeD Pharma, received the backing of Belgian families, entrepreneurs active in the life sciences and public authorities to raise new funds. The €45 million raised will allow ... |
| 09.12.2021 | EIB invests €20M in Belgium-based miDiagnostics to help bring the pandemic under control | Belgium-based miDiagnostics, a company developing a next-generation diagnostic platform based on silicon nanofluidic processor, announced that it has signed a €20M loan agreement with the European Investment Bank (EIB). With this investment... |
| 30.04.2021 | miDiagnostics accelerates with launch of rapid COVID-19 PCR test product | miDiagnostics accelerates with launch of rapid COVID-19 PCR test product Additional funding of 58 million euro for transition to a commercial company Leuven (Belgium), April 30, 2021 - miDiagnostics, a spin-off of the world-leading nano-ele... |
| 26.03.2020 | Leuven-based miDiagnostics gets €14 million to commercialise remote clinical testing | miDiagnostics, a Belgian health tech startup developing silicon chip technology for clinical tests, has raised €14 million from existing investors, plus Dr. Rudi Pauwels and Dr. Ir. Urbain Vandeurzen. MiDiagnostics aims to make “diagnostic ... |
| 11.11.2016 | Emocha adds another wrinkle to mHealth business in deal with diagnostic lab test developer | miDIAGNOSTICS’ approach relies on a few drops of blood. The company’s technology could be used to do a complete blood count test — either to diagnose disease or to monitor a medical condition, a Baltimore Sun article noted. Here’s a short d... |
Show more